Transferrin receptor-targeted immunostimulant for photodynamic immunotherapy against metastatic tumors through <i>β</i>-catenin/CREB interruption.

Acta Pharm Sin B · 2024 · PMC11413667 · PMID 39309507

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

2 A, 4T1 cells cultured with PTI and PT were observed a clear trend of cumulative uptake with increasing drug doses.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.